Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Undaunted Bio Inc. is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The portfolio involves 1 distinct examiner and a distinct art unit, indicating a highly concentrated prosecution effort. This level of focus is common for emerging entities in the biotechnology sector where a single core technology is under review.
GENBIN SHI serves as the busiest examiner for the company, currently handling the 1 pending office action. This assignment means that the primary point of contact for the company's current prosecution is the identified examiner. For the company, this means that the pending office action is subject to the specific interpretation and requirements of the identified examiner. Practitioners should focus on addressing the particular concerns of this examiner, as there are no other pending matters to provide a broader view of the art unit's current stance on similar technologies.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHI, GENBIN | 1 | — | — |
| Art Unit | Apps |
|---|---|
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18934671 | COMPOSITIONS AND METHODS FOR TREATING PAIN | SHI, GENBIN | 1628 | §103§112DP | Non-Final OA | — | Pending | Nov 01, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUndaunted Bio Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Genbin Shi has the most, with 1 of Undaunted Bio Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
